Member-only story

Cardiology Trends in 2024 Include New Heart Failure Treatments, Obesity Drug Benefits, and a Novel Drug to Lower Lp(a)

My yearly review of what is new in Cardiology is explained in plain language.

David Mokotoff, MD
5 min readDec 31, 2024
Photo by BoliviaInteligente on Unsplash

(Author’s note: This post was taken from my Substack and published today, 12/31/24.)

I have been on Substack for less than one year. However, starting this week, I will provide you with a year-end review of the most important studies and trends in Cardiology. My brief reviews are not meant to delve deep into these hot trends. Many will not be published until next year but were presented at Cardiology meetings in the USA and Europe. Without further delay, the following were the hot topics in 2024.

A New Drug to Treat Heart Failure

6.7 million people in the USA are afflicted with congestive heart failure. (Congestive Heart Failure, or CHF, is the same as heart failure, or HF). Traditionally, it was thought that HF was caused by an enlarged and weakened heart muscle. There are many causes. However, over the past couple of decades, it has been recognized that many HF patients had what appeared to be normal heart pumping function or ejection fraction but still suffered from the disease. This has been labeled as HFpEF (for Heart Failure with…

--

--

David Mokotoff, MD
David Mokotoff, MD

Written by David Mokotoff, MD

David Mokotoff is a top and boosted writer. He is a retired MD, passionate about health, medicine, gardening, and food, https://tinyurl.com/y7bjoqkd

Responses (4)